Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I cannot understand why it is taking so long for NNVC to initiate toxicity tests.
One man's marketing is another man's pump. Just get the damn tox tests going and it won't matter how many investor videos Dr. Seymour appears in.
Poor dear, hates to be reminded that when all is said and done none of this matters if human testing isn't done, and tox tests are a prerequisite for that.
Yes, while it's nice to see the NNVC stock price at levels it hasn't been at in two years, I am still watching the days tick by with no announcement of tox testing having started. If they don't start by the end of September NNVC has officially failed to meet one of their own deadlines yet again.
I would consider that a serious misuse of their funds. The price rise you get from pumping a stock is inherently short term in nature. Once the wide eyed yokels stop buying down the price goes. So that would be a terrible way to get a stock price suitable for listing on a major exchange. You qualify, get your stock listed, and then down it goes, until it's under $1 again and the exchange starts to initiate a de-listing. Pumping is for insiders who want to dump their shares and get out of town.
You're dreaming. On the quickest plausible schedule phase I/IIa tests would be completed near the end of 2014. That's still a long, long way from FDA approval.
Nothing clueless about it. Only a fool bets that the FDA will be capricious in a positive way. Sure, it would be nice to get a Breakthrough designation for Flucide, and it's possible that will happen, but no rational investor would assume it. It is more than likely that it will be several years before Flucide is approved for sale in the U.S. My optimistic estimate is end of 2016.
It amazes me how, after NNVC has been spinning its wheels for so many years, people now assume it's going to zip along like a Formula I racer.
NNVC loves a press release. I'm sure that if the tox studies were already underway we would have heard about it.
The stock dropped because NNVC missed the deadlines on all of its pipelines. By years.
"Manipulators" would not have been able to create a two year downtrend in the stock price had NNVC been making clear tangible progress to getting a drug approved. To date we have nothing but lab results on mice and bunnies. And we had that years ago.
Using the Top 400 Companies as your basis for comparing anything to NNVC is ridiculous.
Try to short NNVC. Just try. Just 100 shares of it. Your broker won't let you.
A large part of the daily trading is short term trades by market makers. They can short the stock.
I am not a market maker. I suspect that the other "bashers" are not either. So we couldn't short the shares if we wanted to. As is usual with OTC stocks, there are no shares available to borrow.
At this point we're not waiting for the FDA to step on the gas. We're waiting for NNVC to step on the gas. As in, start the tox tests, rather than issue more press releases.
How do you consider tht FLUCIDE did anything deadly to any mice?
You are assuming that Flucide does not alter any cell function. Just because it wasn't designed to alter cell function doesn't mean that it won't.
Clearly flucide did not kill the mice outright.
There are lots of drugs that don't kill mice when you give them a single dose that turn out to be too toxic for human use.
No, phase I trials are done with healthy volunteers. The point is to determine safety and tolerable dosage levels, not efficacy.
To be precise here is everything Dr. Seymour said about tox testing in the video:
"...toxicology studies have been contracted with the company."
That's it. Nothing we didn't already know, no schedule.
Except that in the video Dr. Seymour doesn't say whether he used rats or mice. He just says, "animals". So watching the video wouldn't enlighten you.
I bet you I did watch the video, which is why I know Dr. Seymour said nothing about the tox tests. The tox tests are not the phase I or IIa trials. They are the prerequisite to the phase I trials, unless you do your phase I trials in a country where there are fools who will volunteer to try a drug that has not been properly tox tested on animals. There was no reason to watch the video four times. What Dr. Seymour said about phase I and IIa testing is what he's been saying for years.
Watching the video should be a Prerequisite for posting on this board.
The grunt work is done? Are you kidding? When not a single drug is approved. Not a single drug is in phase 3 testing. Not a single drug is in phase 2 testing. Not a single drug is in phase 1 testing. Not a single drug is in tox testing.
The grunt work has hardly started. It's at least 5 years too soon to even think about selling off the viral side of the business (currently the only side of the business). With a very long list of viral diseases out there, I see no reason why NNVC would ever sell off the viral side of the business. That would be like Coca Cola deciding to sell off the soda pop side of the business.
Yes, Patrick Cox has had a great influence on his investors. He's drained their brokerage accounts.
I guess I can take some small comfort in the knowledge that if I take a bath on this stock Cox will too.
Without financial analysis the rest is worthless. What is the point of buying a stock with breakthrough technology if it goes bankrupt before it ever has a product? Or if it is forced to dilute its shares, over and over, to keep the lights on? Successful investing in start ups absolutely requires looking at the numbers.
Those of his subscribers that haven't given up in disgust know that if they want to buy one of the stocks he recommends they should wait until the price is less than 50% of what it was when Cox first recommended it.
I have read a number of his write ups. Financial analysis is never present.
It's a strong rebuttal. How never to fail: Do nothing. NNVC has come pretty close to that strategy.
Okay, I missed that one. Still, anybody buying Cox recommendations is still looking at an awful lot of red ink overall.
To my knowledge Patrick Cox never does a financial analysis. He recommends any start up with sufficiently cool technology. I never see hard numbers in his write ups. No estimate of market size, no calculation of burn rate, nothing.
Broken deadlines can be unrecoverable if a company keeps bleeding cash while getting nothing done. How could NNVC have any failures when it keeps delaying the very objective measures (tox tests and clinical trials) that could provide the failures?
You make an important point -- if you're going to short a Cox recommendation, wait for the initial short term spike in the price that's due to the recommendation. Then short the bejeesus out of the stock.
If that's the reason for the recent uptick in the price it's going to be another flash in the pan. The market as a whole doesn't give a damn if Patrick Cox buys a stock.
Definately true. Cox recommended Biotime when it was 0.70 a share, and that one is up by a factor of 5. But every other stock he recommended plunged after his recommendation. Here's how to make steady money from Cox's picks: Short every stock he recommends when he recommends them, with a 50% stop loss. You'd have lost money on Biotime, and made money hand over fist on everything else. Unfortunately there is a practical difficulty. Most of the stocks he recommends are OTC, so you can't short them, unless you're a market maker. (Every sure fire get rich scheme has a fatal flaw.)
The good thing about NNVC is I know when to sell. Some time back they said tox testing would begin June -2/+3 months, i.e., April to September, 2013. Of course only a very naive person would have expected it to start in April or May, and it looks like it's not happening in June either. On October 1, if no tox testing has begun, I sell my shares. There will have been one lie too many.
NNVC will not make money until it has a product it can sell. If NNVC is simply a science project then you, I, and everyone else was a damn fool to buy it. It is irrelevant that NNVC has seen $3 a share before (in the distant past). I can show you any number of tech stocks that in 1999 or 2000 saw prices an order of magnitude higher than they've ever seen since.
Several years back people believed the hype -- that clinical trials were imminent within a year. Now we know that every year clinical trials get pushed back a year.
And none of those variations on Flucide have gone through even the first step towards approval -- completed toxicity tests. NNVC can whip up a new 'cide-of-the-week from now until doomsday and it won't matter if they can't get even one 'cide all the way through FDA approval.
Bacteria are much bigger than viruses and their membranes are very different from the outer coat of viruses. So the ability to make viruses self destruct doesn't mean that you have any particular edge in making bacteria self destruct. Someday there will be a successful nano attack on bacteria but there are any number of other companies that might get there before NNVC does.
Yup, or, Big Kahuna was wrong again in one of his price predictions.
If it's still below $1 ten days from now his end of June price prediction will also be wrong.
Me, I see no reason for this stock to go anywhere until tox tests are completed (they haven't started). If and when tox tests are finished, and they show no significant toxicity, then we'll see $1. Right now all the market sees from NNVC is a lot of smoke, it never sees any fire. We don't need more speeches from Dr. Seymour where he claims he can whip up a new 'cide in two weeks. We need proof he can get one 'cide to market in less than 12 years.
This doesn't surprise me in the least. Big pharma has seen a zillion drugs that worked dandy in rats but were unsafe or ineffective in humans. Remember, the people who run those companies don't live within the reality distortion field of the Investors Hub NNVC board. Unlike many of the posters here, they don't "know", as a certainty or near certainty, that Flucide will be safe and effective in humans. If and when phase IIa trials are completed, and assuming that the results are positive, then we we see big pharma show some interest.